WASHINGTON, DC - House Energy and Commerce Committee Chairman Greg Walden (R-OR) and Health Subcommittee Chairman Michael C. Burgess, M.D. (R-TX) today issued the following statement after the U.S. Senate voted to confirm Scott Gottlieb as the next U.S. Food and Drug Administration (FDA) Commissioner.
“The confirmation of Scott Gottlieb to be the next FDA Commissioner is an important appointment, particularly as we work to reauthorize the agency’s user fees. We are at a critical juncture in the effort to help accelerate the discovery, development, and delivery of new cures and treatments, and Scott will be an important ally in that journey. We can think of no one better to be at the helm than Scott. He’s a trusted physician, former FDA official, and cancer survivor. Scott’s experiences in all of those capacities make him well-equipped for the vast challenges that await him."
